Federal Watchdogs Urge More Oversight of Drug Discount Program
Officials from two federal watchdogs told a Senate committee Tuesday that a drug discount program for hospitals needs additional transparency and oversight to effectively monitor participants. The so-called 340B program, which allows safety net hospitals access to discounted drugs for providing uncompensated care, has become a flashpoint between drug manufacturers that claim providers drive up prices by…